BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35952389)

  • 1. Study on the biological mechanism of urolithin a on nasopharyngeal carcinoma
    Yang Y; Ren ZZ; Wei WJ; He ZL; Deng YL; Wang Z; Fan YC; Zhou J; Jiang LH
    Pharm Biol; 2022 Dec; 60(1):1566-1577. PubMed ID: 35952389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentagalloylglucose suppresses the growth and migration of human nasopharyngeal cancer cells via the GSK3β/β-catenin pathway in vitro and in vivo.
    Fan CW; Tang J; Jiang JC; Zhou MM; Li MS; Wang HS
    Phytomedicine; 2022 Jul; 102():154192. PubMed ID: 35636179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeic acid phenethyl ester suppressed growth and metastasis of nasopharyngeal carcinoma cells by inactivating the NF-κB pathway.
    Liang Y; Feng G; Wu L; Zhong S; Gao X; Tong Y; Cui W; Qin Y; Xu W; Xiao X; Zhang Z; Huang G; Zhou X
    Drug Des Devel Ther; 2019; 13():1335-1345. PubMed ID: 31118570
    [No Abstract]   [Full Text] [Related]  

  • 4. Lucialdehyde B suppresses proliferation and induces mitochondria-dependent apoptosis in nasopharyngeal carcinoma CNE2 cells.
    Liu L; Yu Z; Chen J; Liu B; Wu C; Li Y; Xu J; Li P
    Pharm Biol; 2023 Dec; 61(1):918-926. PubMed ID: 37323017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DLC-1 induces mitochondrial apoptosis and epithelial mesenchymal transition arrest in nasopharyngeal carcinoma by targeting EGFR/Akt/NF-κB pathway.
    Huang W; Liu J; Feng X; Chen H; Zeng L; Huang G; Liu W; Wang L; Jia W; Chen J; Ren C
    Med Oncol; 2015 Apr; 32(4):115. PubMed ID: 25779535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of EB virus miR-BART4 inhibits proliferation and aggressiveness while promoting radiosensitivity of nasopharyngeal carcinoma.
    Wu Q; Han T; Sheng X; Zhang N; Wang P
    Biomed Pharmacother; 2018 Dec; 108():741-751. PubMed ID: 30248542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXG1 improves mitochondrial function and promotes the progression of nasopharyngeal carcinoma.
    Xi H; He Z; Lv C
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term stimulation with histone deacetylase inhibitor trichostatin a induces epithelial-mesenchymal transition in nasopharyngeal carcinoma cells without increasing cell invasion ability.
    Shen Z; Liao X; Shao Z; Feng M; Yuan J; Wang S; Gan S; Ha Y; He Z; Jie W
    BMC Cancer; 2019 Mar; 19(1):262. PubMed ID: 30902084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shikonin inhibits growth, invasion and glycolysis of nasopharyngeal carcinoma cells through inactivating the phosphatidylinositol 3 kinase/AKT signal pathway.
    Zhang J; Zhou J; Xiao S
    Anticancer Drugs; 2020 Oct; 31(9):932-941. PubMed ID: 32282369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pectolinarigenin Suppresses the Tumor Growth in Nasopharyngeal Carcinoma.
    Wang C; Cheng Y; Liu H; Xu Y; Peng H; Lang J; Liao J; Liu H; Liu H; Fan J
    Cell Physiol Biochem; 2016; 39(5):1795-1803. PubMed ID: 27744436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oridonin Induces Apoptosis in Human Nasopharyngeal Carcinoma Cells Involving ROS Generation.
    Zhang P; Zhao SR; Liu F; Sun XJ; Liu H
    Folia Biol (Praha); 2017; 63(4):155-163. PubMed ID: 29256858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of natural compound garcinone E as a novel autophagic flux inhibitor with anticancer effect in nasopharyngeal carcinoma cells.
    Wei D; Wang L; Lei S; Zhang H; Dong C; Ke Y; Su Y; Chen X; Xia L; Kong X; Yin F; Liu X
    Pharm Biol; 2023 Dec; 61(1):839-857. PubMed ID: 37203204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AG4, a compound isolated from Radix Ardisiae Gigantifoliae, induces apoptosis in human nasopharyngeal cancer CNE cells through intrinsic and extrinsic apoptosis pathways.
    Dong XZ; Xie TT; Zhou XJ; Mu LH; Zheng XL; Guo DH; Liu P; Ge XY
    Anticancer Drugs; 2015 Mar; 26(3):331-42. PubMed ID: 25521557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer effects of brusatol in nasopharyngeal carcinoma through suppression of the Akt/mTOR signaling pathway.
    Guo S; Zhang J; Wei C; Lu Z; Cai R; Pan D; Zhang H; Liang B; Zhang Z
    Cancer Chemother Pharmacol; 2020 Jun; 85(6):1097-1108. PubMed ID: 32449143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Hispidulin, a Flavonoid from
    Dai Y; Sun X; Li B; Ma H; Wu P; Zhang Y; Zhu M; Li HM; Qin M; Wu CZ
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33799348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (S,R)3-(4-Hydroxyphenyl)-4,5-Dihydro-5-Isoxazole Acetic Acid Methyl Ester Inhibits Epithelial-to-Mesenchymal Transition Through TGF-β/Smad4 Axis in Nasopharyngeal Carcinoma.
    Chen Q; Wang Y; Li F; Cheng X; Xiao Y; Chen S; Xiao B; Tao Z
    Anticancer Agents Med Chem; 2022; 22(6):1080-1090. PubMed ID: 34229595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
    Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
    FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium selenite (Na2SeO3) induces apoptosis through the mitochondrial pathway in CNE-2 nasopharyngeal carcinoma cells.
    Cui Z; Li C; Li X; Zhang Q; Zhang Y; Shao J; Zhou K
    Int J Oncol; 2015; 46(6):2506-14. PubMed ID: 25891011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Niflumic acid exhibits anti-tumor activity in nasopharyngeal carcinoma cells through affecting the expression of ERK1/2 and the activity of MMP2 and MMP9.
    Luo S; Huang G; Wang Z; Wan Z; Chen H; Liao D; Chen C; Li H; Li B; Chen L; Huang Z; He Z
    Int J Clin Exp Pathol; 2015; 8(9):9990-10001. PubMed ID: 26617707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC00240 knockdown inhibits nasopharyngeal carcinoma progress by targeting miR-26a-5p.
    Chen X; Wu G; Qing J; Li C; Chen X; Shen J
    J Clin Lab Anal; 2022 May; 36(5):e24424. PubMed ID: 35421264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.